Product Information

BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.6695 per EA under NDC 65162041503. Its NADAC has been published 657 times since Nov 28, 2013.

BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET

Buprenorphine and Naloxone
$0.6695per EA
DEA Schedule CIII

Strength

8; 2 mg/1; mg/1

NDC

65162041503

Classification

Generic

Dosage Form

TABLET

Route

SUBLINGUAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA203136

On Market Since

2/22/2013

Pharmacological Classes

Opioid Antagonist
Opioid Antagonists
Partial Opioid Agonist
Partial Opioid Agonists

Price Statistics

The NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 89.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6695 per EA
All-time high$6.3368 (Dec 11, 2013)
All-time low$0.6450 (Nov 20, 2024)
52-week high$0.7397
52-week low$0.6616
Median price$1.4886
Average price$2.5016
Largest weekly change+29.6% (Aug 21, 2024)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-1.3%

3M

+1.2%

6M

-6.9%

1Y

-6.8%

3Y

-32.3%

5Y

-39.1%

All

-89.4%

Generic Alternatives

The matcher finds 9 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 9 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.6695 per EA (NDC 65162041503), effective Jun 24, 2026.

How has the price of BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET changed over time?

Over the history we have for it, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has declined 89.4%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?

Since Nov 28, 2013, the NADAC for BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET has ranged from a low of $0.6450 (Nov 20, 2024) to a high of $6.3368 (Dec 11, 2013), with a median of $1.4886 per EA.

Are there cheaper alternatives to BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?

9 NADAC-published products share the same active ingredient, strength, and dosage form as BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET, but none are currently priced below it.

Who manufactures BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET?

BUPRENORPHINE-NALOXONE 8-2 MG SL TABLET (NDC 65162041503) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.